NeutraSal helps treat symptoms of xerostomia and helps restore the oral environment1,2


NeutraSal is a prescription supersaturated calcium phosphate rinse that mimics saliva


  • Dissolves in water to form a unique oral rinse with added sodium bicarbonate to help perform the functions of saliva
    • Improves xerostomic symptoms across a range of severities
    • Restores healthy pH balance in the oral cavity

NeutraSal: patient-friendly oral rinse for the treatment of xerostomia1

Ease of use

  • Single-use packet dose dissolves in water to create oral rinse
  • Patients swish rinse for 2 minutes
  • Can be used 2 to 10 times a day, as needed

Established safety

  • Nonsystemic
  • No anticipated adverse effects if ingested
  • No known interactions with medicinal or other products
  • NeutraSal is not intended for systemic use to treat any diseases of the throat or upper gastrointestinal tract
  • NeutraSal is not intended to prevent dry mouth
  • Avoid eating or drinking for at least 15 minutes after use
  • NeutraSal contains sodium; patients restricted to a low-sodium diet should consult their physician before use

Proven effective in the treatment of xerostomia

In dental patients with varying degrees of xerostomic symptoms2*

  • 93% of patients showed decrease in S. mutans population
  • Average salivary pH improved from 5.9 to 7.0

*Dental patients with varying degrees of xerostomic symptoms (n=30) rinsed with NeutraSal 2 to 3 times a day for 28 days.

Note: These symptoms do not represent all potential xerostomia symptoms that patients may experience.

In medication-induced xerostomia3†

  • Average resting pH increased from 5.93 to 7.01

†Patients with medication-induced xerostomia and a low resting salivary pH (<6.5) in the oral cavity were treated with NeutraSal (2.3 mean rinses daily) for 28 days (n=10).

  •     Learn more about the beneficial effects of a supersaturated calcium phosphate rinse

INDICATIONS

NeutraSal® is indicated for dryness of the mouth (hyposalivation, xerostomia) and dryness of the oral mucosa due to drugs that suppress salivary secretion.

IMPORTANT SAFETY INFORMATION

  • Not intended to prevent xerostomia or oral mucositis.
  • Patients should avoid eating or drinking for at least 15 minutes after use
  • Solution should not be swallowed but be spit out.
  • Not intended for systemic use to treat any diseases of the throat or upper gastrointestinal tract
  • Not intended for use as an antacid
  • No adverse events anticipated if swallowed accidentally
  • Contains sodium; Patients restricted to a low-sodium diet should consult their physician before use.
  • No known interactions with medicinal or other products

Please click here for Instructions for Use.